Banking_Competition_Remed - Accounts


Company Registration No. 11001491 (England and Wales)
Banking Competition Remedies Limited
Annual report and financial statements
for the year ended 30 April 2020
Banking Competition Remedies Limited
Company information
Directors
Brendan Peilow
Aidene Walsh
John Howard (non-executive director)
Richard Anderson (non-executive director)
(Appointed 13 January 2020)
Company number
11001491
Registered office
84 Eccleston Square
London
SW1V 1PX
Independent auditor
Saffery Champness LLP
St Catherine's Court
Berkeley Place
Clifton
Bristol
BS8 1BQ
Banking Competition Remedies Limited
Contents
Page
Directors' report
1
Directors' responsibilities statement
2
Independent auditor's report
3 - 5
Statement of comprehensive income
6
Statement of financial position
7
Statement of changes in equity
8
Notes to the financial statements
9 - 16
Banking Competition Remedies Limited
Directors' report
For the year ended 30 April 2020
Page 1

The directors present their annual report and financial statements for the year ended 30 April 2020.

Principal activities

The company was incorporated on 6 October 2017 with its principal activity of ensuring the  implementation of  the Alternative Remedies Package (“ARP”) of measures agreed between the UK Government and the European Commission.   The company is not set up to make profit but instead receives funding to cover the costs incurred in fulfilling its purpose. The lifetime of the company is limited solely to the period of implementing the ARP (and Winding Up must commence no later than 25th April 2023).

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Godfrey Cromwell
(Resigned 30 September 2020)
Brendan Peilow
Aidene Walsh
Nigel Vooght (non-executive director)
(Resigned 24 May 2019)
John Howard (non-executive director)
Richard Anderson (non-executive director)
(Appointed 13 January 2020)
Auditor

Saffery Champness LLP were appointed as auditor to the company and in accordance with section 485 of the Companies Act 2006, a resolution proposing that they be re-appointed will be put at a General Meeting.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
Brendan Peilow
Director
26 October 2020
Banking Competition Remedies Limited
Directors' responsibilities statement
For the year ended 30 April 2020
Page 2

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

 

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the surplus or deficit of the company for that period. In preparing these financial statements, the directors are required to:

 

  •     select suitable accounting policies and then apply them consistently;

  •     make judgements and accounting estimates that are reasonable and prudent;

  •     prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

 

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Banking Competition Remedies Limited
Independent auditor's report
To the members of Banking Competition Remedies Limited
Page 3
Opinion

We have audited the financial statements of Banking Competition Remedies Limited (the 'company') for the year ended 30 April 2020 which comprise the statement of comprehensive income, the statement of financial position, the statement of changes in equity and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

  •     give a true and fair view of the state of the company's affairs as at 30 April 2020 and of its surplus for the year then ended;

  •     have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

  •     have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

We have nothing to report in respect of the following matters in relation to which the ISAs (UK) require us to report to you where:

  • the directors' use of the going concern basis of accounting in the preparation of the financial statements is not appropriate; or

  • the directors have not disclosed in the financial statements any identified material uncertainties that may cast significant doubt about the company’s ability to continue to adopt the going concern basis of accounting for a period of at least twelve months from the date when the financial statements are authorised for issue.

Banking Competition Remedies Limited
Independent auditor's report (continued)
To the members of Banking Competition Remedies Limited
Page 4

Other information

The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor's report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

 

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

 

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

  • the information given in the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

  • the directors' report has been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the directors' report.

 

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

 

  •     adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

  •     the financial statements are not in agreement with the accounting records and returns; or

  •     certain disclosures of directors' remuneration specified by law are not made; or

  •     we have not received all the information and explanations we require for our audit; or

  •     the directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies' exemption in preparing the directors' report and take advantage of the small companies exemption from the requirement to prepare a strategic report.

Banking Competition Remedies Limited
Independent auditor's report (continued)
To the members of Banking Competition Remedies Limited
Page 5
Responsibilities of directors

As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

 

In preparing the financial statements, the directors are responsible for assessing the company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: http://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members, as a body, for our audit work, for this report, or for the opinions we have formed.

Neil Davies (Senior Statutory Auditor)
for and on behalf of Saffery Champness LLP
26 October 2020
Chartered Accountants
Statutory Auditors
St Catherine's Court
Berkeley Place
Clifton
Bristol
BS8 1BQ
Banking Competition Remedies Limited
Statement of comprehensive income
For the year ended 30 April 2020
Page 6
2020
2019
as restated
£'000
£'000
Income
2,521
4,459
Administrative expenses
(2,536)
(4,465)
Operating deficit
3
(15)
(6)
Interest receivable and similar income
6
19
8
Surplus before taxation
4
2
Tax expense
(4)
(2)
Surplus for the financial year
-
-

The income and expenditure account has been prepared on the basis that all operations are continuing operations.

Banking Competition Remedies Limited
Statement of financial position
As at 30 April 2020
Page 7
2020
2019
as restated
Notes
£'000
£'000
£'000
£'000
Fixed assets
Tangible assets
7
13
24
Current assets
Debtors
8
42
35
Cash at bank and in hand
5,361
2,867
5,403
2,902
Creditors: amounts falling due within one year
9
(5,416)
(2,926)
Net current liabilities
(13)
(24)
Total assets less current liabilities
-
-

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 22 October 2020 and are signed on its behalf by:
Brendan Peilow
Director
Company Registration No. 11001491
Banking Competition Remedies Limited
Statement of changes in equity
For the year ended 30 April 2020
Page 8
Income and expenditure
£'000
As restated for the period ended 30 April 2019:
Balance at 1 May 2018
(731)
Effect of prior year adjustment
731
As restated
-
Year ended 30 April 2019:
Profit and total comprehensive income for the year
-
Balance at 30 April 2019
-
Year ended 30 April 2020:
Profit and total comprehensive income for the year
-
Balance at 30 April 2020
-
Banking Competition Remedies Limited
Notes to the financial statements
For the year ended 30 April 2020
Page 9
1
Accounting policies
Company information

Banking Competition Remedies Limited is a private company limited by guarantee incorporated in England and Wales. The registered office is 84 Eccleston Square, London, SW1V 1PX.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £1,000.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources and support to continue in operational existence. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Income and expenditure

Income represents cash received to cover the costs incurred in fulfilling its principal activity and is recognised in the year in which the costs occur.

 

Interest earned on any cash balances is recognised as income in the period to which it relates.

 

Expenses include VAT where applicable as the company is not VAT registered and therefore cannot reclaim it.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
33% straight line
Computers
33% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to surplus or deficit.

Banking Competition Remedies Limited
Notes to the financial statements (continued)
For the year ended 30 April 2020
1
Accounting policies (continued)
Page 10
1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in surplus or deficit, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in surplus or deficit, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Banking Competition Remedies Limited
Notes to the financial statements (continued)
For the year ended 30 April 2020
1
Accounting policies (continued)
Page 11
Impairment of financial assets

Financial assets are assessed for indicators of impairment at each reporting end date.

 

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in surplus or deficit.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

1.7
Taxation

The company is exempt from claiming trading losses on the basis that it is a company not carrying on a business for the purposes of making a profit. Tax is payable on any interest income received.

1.8
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

 

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

1.9
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.10
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

Banking Competition Remedies Limited
Notes to the financial statements (continued)
For the year ended 30 April 2020
Page 12
2
Critical accounting judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Operating deficit
2020
2019
Operating deficit for the year is stated after charging:
£'000
£'000
Fees payable to the company's auditor for the audit of the company's financial statements
9
10
Depreciation of owned tangible fixed assets
11
11
Operating lease charges
244
249
Non-audit fees
2
2
4
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2020
2019
Number
Number
Administration
10
9

Their aggregate remuneration comprised:

2020
2019
£'000
£'000
Wages and salaries
758
667
Social security costs
88
81
Pension costs
9
6
855
754
Banking Competition Remedies Limited
Notes to the financial statements (continued)
For the year ended 30 April 2020
Page 13
5
Directors' remuneration
2020
2019
£'000
£'000
Remuneration for qualifying services
386
350
Remuneration disclosed above include the following amounts paid to the highest paid director:
2020
2019
£'000
£'000
Remuneration for qualifying services
132
130
6
Interest receivable and similar income
2020
2019
£'000
£'000
Interest income
Interest on bank deposits
19
8

Investment income includes the following:

Interest on financial assets not measured at fair value through surplus or deficit
19
8
Banking Competition Remedies Limited
Notes to the financial statements (continued)
For the year ended 30 April 2020
Page 14
7
Tangible fixed assets
Fixtures and fittings
Computers
Total
£'000
£'000
£'000
Cost
At 1 May 2019 and 30 April 2020
1
34
35
Depreciation and impairment
At 1 May 2019
-
11
11
Depreciation charged in the year
-
11
11
At 30 April 2020
-
22
22
Carrying amount
At 30 April 2020
1
12
13
At 30 April 2019
1
23
24
8
Debtors
2020
2019
Amounts falling due within one year:
£'000
£'000
Other debtors
5
5
Prepayments and accrued income
37
30
42
35
9
Creditors: amounts falling due within one year
2020
2019
£'000
£'000
Trade creditors
113
46
Corporation tax
4
2
Other taxation and social security
25
33
Deferred income
10
5,224
2,824
Accruals
50
21
5,416
2,926
Banking Competition Remedies Limited
Notes to the financial statements (continued)
For the year ended 30 April 2020
Page 15
10
Deferred income
2020
2019
£'000
£'000
Payments received in advance
5,224
2,824
11
Retirement benefit schemes
2020
2019
Defined contribution schemes
£'000
£'000
Charge to profit or loss in respect of defined contribution schemes
9
6

The company operates a defined contribution pension scheme for all qualifying employees. The assets of the scheme are held separately from those of the company in an independently administered fund.

12
Members' liability

The company is limited by guarantee, not having a share capital and consequently the liability of members is limited, subject to an undertaking by each member to contribute to the net assets or liabilities of the company on winding up such amounts as may be required not exceeding £1.

13
Operating lease commitments
Lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, which fall due as follows:

2020
2019
£'000
£'000
Within one year
247
242
Banking Competition Remedies Limited
Notes to the financial statements (continued)
For the year ended 30 April 2020
Page 16
14
Prior period adjustment

The budget for BCR was established at the outset and the total for the whole life of the company paid by RBS (now NatWest) into an escrow account at the Bank of England administered by the independent Monitor, Mazars. Predetermined amounts for each year are paid from the escrow account on the instructions of Mazars into the business current account of BCR at HSBC. The money is used solely to cater for the annual operating expenses of BCR in its role of administering the Incentivised Switching Scheme and the Capability and Innovation Fund in its role as corporate trustee to the Alternative Remedies Package Trust.

 

The prior year adjustment follows an internal review of all the related documentation in respect of the total monies paid into the Escrow Account at the outset and their accounting treatment when paid annually to BCR. After consideration, the directors have deemed it more appropriate that the annual receipt is treated as income rather than capital with any in-year surplus treated as deferred income against future expenses. There is no impact on the cashflow of BCR.

Changes to the statement of financial position
As previously reported
Adjustment
As restated at 30 Apr 2019
£'000
£'000
£'000
Creditors due within one year
Deferred income
-
(2,824)
(2,824)
Net assets
2,824
(2,824)
-
Capital and reserves
Other reserves
8,013
(8,013)
-
Income and expenditure account
(5,189)
5,189
-
Total equity
2,824
(2,824)
-
Changes to the income statement
As previously reported
Adjustment
As restated
Period ended 30 April 2019
£'000
£'000
£'000
Turnover
-
4,459
4,459
(Deficit)/surplus for the financial period
(4,459)
4,459
-
2020-04-302019-05-01falseCCH SoftwareCCH Accounts Production 2019.301lBrendan PeilowGodfrey CromwellNigel Vooght (non-executive director)Brendan PeilowAidene Walsh0110014912019-05-012020-04-3011001491bus:Director52019-05-012020-04-3011001491bus:Director62019-05-012020-04-3011001491bus:Director82019-05-012020-04-3011001491bus:Director92019-05-012020-04-3011001491bus:Director32019-05-012020-04-3011001491bus:Director72019-05-012020-04-3011001491bus:Director12019-05-012020-04-3011001491bus:Director22019-05-012020-04-3011001491bus:Director42019-05-012020-04-3011001491bus:RegisteredOffice2019-05-012020-04-30110014912020-04-30110014912018-05-012019-04-3011001491core:ContinuingOperations2018-05-012019-04-30110014912019-04-3011001491core:FurnitureFittings2020-04-3011001491core:ComputerEquipment2020-04-3011001491core:FurnitureFittings2019-04-3011001491core:ComputerEquipment2019-04-3011001491core:CurrentFinancialInstrumentscore:WithinOneYear2020-04-3011001491core:CurrentFinancialInstrumentscore:WithinOneYear2019-04-3011001491core:CurrentFinancialInstruments2020-04-3011001491core:CurrentFinancialInstruments2019-04-3011001491core:RetainedEarningsAccumulatedLossescore:PriorPeriodIncreaseDecrease2018-04-3011001491core:FurnitureFittings2019-05-012020-04-3011001491core:ComputerEquipment2019-05-012020-04-3011001491core:OwnedAssets2019-05-012020-04-3011001491core:OwnedAssets2018-05-012019-04-3011001491core:FurnitureFittings2019-04-3011001491core:ComputerEquipment2019-04-30110014912019-04-3011001491core:WithinOneYear2020-04-3011001491core:WithinOneYear2019-04-3011001491bus:CompanyLimitedByGuarantee2019-05-012020-04-3011001491bus:FRS1022019-05-012020-04-3011001491bus:Audited2019-05-012020-04-3011001491bus:FullAccounts2019-05-012020-04-30xbrli:purexbrli:sharesiso4217:GBP